Document 0873 DOCN M9540873 TI Expression of a Tat-inducible herpes simplex virus-thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription. DT 9504 AU Caruso M; Salomon B; Zhang S; Brisson E; Clavel F; Lowy I; Klatzmann D; Laboratoire de Biologie et Genetique des Pathologies; Immunitaires, CNRS URA D1463, Hopital de la; Pitie-Salpetriere, Paris, France. SO Virology. 1995 Jan 10;206(1):495-503. Unique Identifier : AIDSLINE MED/95133185 AB Cellular expression of the herpes simplex virus type 1 thymidine kinase (HSV1-TK) gene promotes cell death in the presence of specific nucleoside analog substrates such as acyclovir (ACV). We have reported that lymphoid CD4+ cells harboring an HSV1-TK gene, under the transcriptional control of the HIV-1 long terminal repeat (HUT-TK), are completely protected from HIV-1 spread in the presence of 10 microM ACV. In this report we clarify the efficiency, generality, and mechanism of this protective effect. We show that the protection from HIV-1 spread in HUT-TK cells obtains from both an inhibition of HIV reverse transcription by ACV metabolites and an HIV-induced and ACV-dependent cell killing. We also demonstrate that monocytic cells harboring the HIV-1-inducible HSV1-TK gene are protected from HIV spread in the presence of ACV. These observations facilitate the design of therapeutic strategies to limit HIV replication based on HSV1-TK expression. DE Acyclovir/*PHARMACOLOGY Cell Death/DRUG EFFECTS Cell Line CD4-Positive T-Lymphocytes/CYTOLOGY/*DRUG EFFECTS/VIROLOGY Gene Products, tat/PHYSIOLOGY HIV-1/DRUG EFFECTS/*PHYSIOLOGY Simplexvirus/*ENZYMOLOGY/GENETICS Support, Non-U.S. Gov't Thymidine Kinase/GENETICS/*METABOLISM Trans-Activation (Genetics) *Transcription, Genetic/DRUG EFFECTS Virus Replication JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).